Researchers in China have developed a novel mouse model of liver fibrosis using a widely used aluminum-based vaccine adjuvant, potentially offering a new platform to study immune-mediated liver injury and test antifibrotic therapies.
In the…

Researchers in China have developed a novel mouse model of liver fibrosis using a widely used aluminum-based vaccine adjuvant, potentially offering a new platform to study immune-mediated liver injury and test antifibrotic therapies.
In the…